Commercialization & Market Access
Your U.S. market entry and growth partner
Breaking into the U.S. market takes more than a great product — it takes the right strategy, the right relationships, and the right infrastructure. Our commercialization and market access team brings the expertise to navigate every layer of the U.S. healthcare landscape, from government programs to distribution partnerships.
Government Programs
Participating in U.S. government healthcare programs including Medicaid, Medicare, and the 340B Drug Pricing Program requires careful planning and ongoing compliance. We help manufacturers understand their obligations, structure their pricing strategies, and manage submissions to ensure your product is accessible to the patients who need it most, while staying fully compliant with federal requirements.
Chargeback & Rebate
Managing chargebacks and rebates is one of the most complex operational challenges in U.S. pharmaceutical commercialization. We work with manufacturers to design, implement, and administer chargeback and rebate programs that align with your contracts, minimize revenue leakage, and maintain accurate reconciliation across wholesalers, distributors, and payers.
Relabeling
Bringing a product to the U.S. market often requires adapting labeling to meet FDA requirements or to reflect local market needs. Our team manages the relabeling process end-to-end coordinating regulatory review, artwork updates, and quality oversight so your product is shelf-ready without unnecessary delays.
Third-Party Relationship Management
A successful U.S. launch depends on a network of distributors, wholesalers, specialty pharmacies, and service providers working in sync. We manage those relationships on your behalf negotiating agreements, monitoring performance, and ensuring every partner is aligned with your commercialization goals so you can focus on growing your business.